Spark Therapeutics, Inc (ONCE) Covered Calls

Spark Therapeutics Inc is a gene therapy company. The Company is engaged in developing one-time, life-altering gene therapy treatments to transform the lives of patients and re-imagine the treatment of debilitating diseases.

You can sell covered calls on Spark Therapeutics, Inc to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for ONCE (prices last updated Fri 4:16 PM ET):

Spark Therapeutics, Inc (ONCE) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
52.77 +2.17 51.75 56.10 826K - 1.9B
Covered Calls For Spark Therapeutics, Inc (ONCE)
Expiration Strike Call Bid Net Debit Return
If Flat		 Annualized
Return If Flat
Mar 15 55 2.30 53.80 2.2% 27.7%
Jun 21 55 6.20 49.90 10.2% 29.3%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial

Extended Business Description

Spark Therapeutics, Inc. engages in gene therapy research, development, manufacturing and clinical trials. The company is developing one-time, life-altering gene therapy treatments to transform the lives of patients and re-imagine the treatment of debilitating diseases. Its initial focus is on treating orphan diseases, and it has demonstrated promising clinical outcomes with its first product candidate targeting rare blinding conditions, which has received both breakthrough therapy and orphan product designation and is in a fully enrolled, pivotal Phase 3 clinical trial. The company also has built a pipeline of product candidates targeting additional blinding conditions, hematologic disorders and neurodegenerative diseases, including a second product candidate targeting another rare blinding condition. Spark Therapeutics was founded by Jeffrey D. Marrazzo, Katherine A. High and Jennifer Wellman on March 13, 2013 and is headquartered in Philadelphia, PA.